Hypopituitarism

Hypopituitarism is a condition in which the pituitary gland fails to produce adequate amounts of one or more of its hormones. Because the pituitary gland acts as the master regulator of the endocrine system, even partial deficiency can cascade into widespread effects on metabolism, reproduction, stress response, growth, and fluid balance. When all anterior pituitary hormones are deficient the condition is called panhypopituitarism. Early recognition and targeted hormone replacement can restore near-normal function and significantly reduce the elevated mortality risk this condition carries when untreated.

Table of Contents

  1. What Hypopituitarism Is
  2. Causes
  3. Which Hormones Fail First
  4. Symptoms by Hormone Deficiency
  5. Pituitary Apoplexy
  6. Sheehan's Syndrome
  7. Diagnosis
  8. Treatment and Hormone Replacement
  9. Research Papers
  10. Connections
  11. Featured Videos

What Hypopituitarism Is

The pituitary gland, a pea-sized structure at the base of the brain seated within the bony sella turcica, is divided into two functionally distinct lobes. The anterior pituitary (adenohypophysis) produces six major hormones under hypothalamic control:

The posterior pituitary (neurohypophysis) stores and releases two hormones produced in the hypothalamus:

Hypopituitarism can be partial (one or a few hormones deficient) or complete (panhypopituitarism, all anterior hormones). The posterior pituitary is more resistant to damage because its axons originate in the hypothalamus, but hypothalamic or pituitary stalk injuries can impair ADH release, causing central diabetes insipidus.

Back to Table of Contents

Causes

Any structural, inflammatory, vascular, infiltrative, or traumatic process affecting the pituitary gland, pituitary stalk, or hypothalamus can cause hypopituitarism.

Pituitary Tumors and Adenomas

The most common cause in adults. Non-functioning pituitary macroadenomas (>10 mm) compress and destroy normal gland tissue. Functioning adenomas — those secreting GH (acromegaly), ACTH (Cushing's disease), or prolactin (prolactinoma) — can also compress the remaining normal gland. Even after successful tumor removal, hypopituitarism frequently persists or develops.

Craniopharyngioma

These benign but locally destructive tumors arise from remnants of Rathke's pouch near the pituitary stalk and hypothalamus. They are the most common cause of hypopituitarism in children and young adults and frequently cause diabetes insipidus due to hypothalamic or stalk involvement.

Pituitary Surgery and Radiation

Transsphenoidal surgery for pituitary tumors can damage normal pituitary tissue. Radiation therapy — whether conventional external beam or stereotactic radiosurgery — causes progressive hypopituitarism in a time-dependent fashion. GH deficiency appears earliest, often within 2 years; other axes may fail over 10 to 15 years. All patients who have received pituitary or cranial radiation require lifelong endocrine monitoring.

Traumatic Brain Injury

An underrecognized and underdiagnosed cause. TBI disrupts the delicate portal blood supply to the anterior pituitary via the hypophyseal portal vessels that run through the pituitary stalk. GH deficiency occurs in approximately 15 to 25 percent of moderate-to-severe TBI survivors; ACTH deficiency occurs in 5 to 10 percent. Symptoms — fatigue, cognitive impairment, mood disturbance — are often wrongly attributed to post-concussive syndrome or depression alone. Endocrine evaluation is now recommended 3 to 6 months after moderate or severe TBI.

Sheehan's Syndrome

Postpartum pituitary infarction resulting from hemorrhagic shock during or after delivery. The physiologically enlarged pituitary gland of pregnancy is exquisitely vulnerable to ischemia when massive postpartum hemorrhage (PPH) causes systemic hypotension. Failure to lactate after delivery, combined with persistent amenorrhea and gradually developing hypothyroid and adrenal insufficiency symptoms, is the classic triad. Described in detail in a dedicated section below.

Lymphocytic Hypophysitis

An autoimmune inflammatory infiltration of the pituitary gland, predominantly affecting women during or shortly after pregnancy. T-lymphocyte infiltration destroys glandular tissue. Unlike most causes of hypopituitarism, ACTH deficiency and ADH deficiency can appear early and disproportionately. MRI shows diffuse pituitary enlargement that may mimic a macroadenoma. Many cases partially recover spontaneously; severe cases may require glucocorticoid treatment or surgery.

Pituitary Apoplexy

Sudden hemorrhage or infarction into a pre-existing pituitary adenoma. Presents as a medical emergency with acute onset of severe headache, visual impairment, and cranial nerve palsies. Described in detail in a dedicated section below.

Granulomatous and Infiltrative Disease

Sarcoidosis, tuberculosis, histiocytosis X (Langerhans cell histiocytosis), and hemochromatosis can all infiltrate the pituitary or hypothalamus. Sarcoidosis has a predilection for the pituitary stalk, often causing diabetes insipidus before anterior hormone deficiencies appear. These diagnoses should be considered when hypopituitarism occurs without a pituitary mass or other obvious structural cause.

Empty Sella Syndrome

The sella turcica appears empty on MRI because cerebrospinal fluid has herniated through a deficient diaphragma sellae, compressing the pituitary against the floor of the sella. Primary empty sella is usually incidental and rarely causes significant hypopituitarism. Secondary empty sella — occurring after pituitary tumor treatment or infarction — is more likely to be associated with hormone deficiencies.

Genetic and Congenital Causes

Mutations in transcription factors essential for pituitary development (POU1F1, PROP1, HESX1, LHX3, LHX4) cause combined pituitary hormone deficiency presenting in childhood. PROP1 mutations are the most common genetic cause of combined hormone deficiency, typically involving GH, TSH, LH/FSH, and sometimes ACTH.

Back to Table of Contents

Which Hormones Fail First

Pituitary damage does not affect all hormones equally. There is a well-established hierarchy of vulnerability that reflects differences in the size and distribution of each cell population within the gland.

  1. Growth hormone (GH) — most common, ~96% with structural pituitary disease. GH-secreting somatotrophs constitute the largest cell population in the anterior pituitary and are most susceptible to compression, radiation, and ischemia. GH deficiency is often the only deficiency found after mild TBI or partial pituitary irradiation.
  2. Gonadotropins (LH/FSH) — second most common. Gonadotroph cells are the next most vulnerable. Gonadotropin deficiency is the second axis to fail with progressive pituitary damage and is frequently the presenting finding in young women (amenorrhea) and men (erectile dysfunction and infertility).
  3. TSH — third. Central hypothyroidism from TSH deficiency is less common than GH or gonadotropin deficiency alone, but becomes increasingly prevalent as pituitary damage progresses.
  4. ACTH — fourth, but most clinically dangerous. ACTH deficiency is less common in mild-moderate pituitary disease but carries the greatest immediate mortality risk. Secondary adrenal insufficiency from ACTH deficiency is life-threatening during physiological stress because cortisol production is absent. Unlike primary adrenal insufficiency (Addison's disease), aldosterone production is preserved (it is controlled by the RAAS system, not ACTH), so severe salt-wasting is not typical.
  5. ADH (posterior pituitary) — least common from isolated anterior damage. The posterior pituitary is supplied by the inferior hypophyseal artery and its axons originate in the hypothalamus, making it more resistant to most causes of anterior hypopituitarism. However, hypothalamic injury, pituitary stalk section (during surgery or from craniopharyngioma), and lymphocytic hypophysitis can cause central diabetes insipidus.
  6. Prolactin — paradoxically elevated, not deficient, in most cases. Dopamine from the hypothalamus tonically inhibits prolactin secretion. Pituitary stalk damage removes this inhibition, causing hyperprolactinemia (which itself suppresses gonadotropin secretion). True prolactin deficiency (inability to lactate) is a hallmark of Sheehan's syndrome.

Back to Table of Contents

Symptoms by Hormone Deficiency

Because multiple axes are often involved, the clinical picture of hypopituitarism is frequently vague and overlapping. Many patients are misdiagnosed with depression, chronic fatigue, or menopause for years before the pituitary origin is recognized.

Growth Hormone Deficiency in Adults

Adult GH deficiency is a distinct clinical syndrome — not simply a lack of growth hormone once the growth plates have fused. Affected adults experience profound fatigue and reduced exercise capacity, increased abdominal visceral fat with decreased lean muscle mass, impaired psychological well-being with increased rates of depression and anxiety, reduced bone mineral density increasing fracture risk, and adverse lipid profiles with elevated LDL and triglycerides. Quality of life impairment is measurable and comparable to other serious chronic diseases.

Gonadotropin (LH/FSH) Deficiency

In women: amenorrhea or oligomenorrhea, infertility, loss of libido, vaginal dryness, and hot flushes. Because estrogen deficiency is central (low LH/FSH → low estradiol), FSH and LH levels are low-normal or normal rather than elevated as in primary ovarian failure. In men: erectile dysfunction, loss of libido, reduced ejaculatory volume, infertility (oligospermia), decreased body hair, and reduced testicular volume. Both sexes develop progressive osteoporosis from sex hormone deficiency.

TSH Deficiency (Secondary/Central Hypothyroidism)

Symptoms mirror primary hypothyroidism — fatigue, weight gain, cold intolerance, constipation, dry skin, bradycardia, and impaired cognition — but the biochemical profile is different. In primary hypothyroidism TSH is elevated; in secondary hypothyroidism TSH is low, normal, or mildly elevated with biologically inactive TSH isoforms. Free T4 is the reliable marker. Failure to recognize this distinction leads to the dangerous error of using TSH alone to monitor thyroid replacement in hypopituitary patients.

ACTH Deficiency (Secondary Adrenal Insufficiency)

The most dangerous deficiency. Cortisol is essential for the stress response, gluconeogenesis, vascular reactivity, and immune regulation. Symptoms at baseline include fatigue, nausea, weight loss, anorexia, mild hypotension, and hypoglycemia. Salt craving and marked hyperpigmentation are absent (those are features of primary Addison's disease where ACTH is elevated). The critical danger is adrenal crisis — when physiological stress such as illness, injury, or surgery dramatically increases cortisol requirements that the deficient patient cannot meet. Adrenal crisis presents with vomiting, severe hypotension, altered consciousness, and circulatory collapse. It is immediately life-threatening and requires emergency intravenous hydrocortisone.

ADH Deficiency (Central Diabetes Insipidus)

Failure of ADH release from the posterior pituitary or hypothalamus causes inability to concentrate urine. Patients produce very large volumes of dilute urine (polyuria, typically 3 to 20 liters per day) and experience intense, continuous thirst (polydipsia). Hypernatremia occurs if fluid intake cannot keep pace with urinary losses, such as during intercurrent illness or after surgical procedures. This must be distinguished from nephrogenic diabetes insipidus (where ADH is normal or elevated but the kidney fails to respond).

Back to Table of Contents

Pituitary Apoplexy

Pituitary apoplexy is a rare but life-threatening endocrine emergency caused by sudden hemorrhage into, or infarction of, a pituitary adenoma. It accounts for approximately 2 to 7 percent of all pituitary adenoma presentations but requires immediate recognition because delayed treatment can result in permanent visual loss, life-threatening adrenal insufficiency, or death.

Clinical Presentation

The hallmark is a sudden, severe "thunderclap" headache — often described as the worst headache of the patient's life — typically retro-orbital or bitemporal in location. Associated features reflect the anatomical neighbors of the pituitary:

Emergency Management

Pituitary apoplexy is managed as a neurosurgical emergency with simultaneous endocrine resuscitation:

  1. Immediate glucocorticoid coverage — hydrocortisone 100 mg IV bolus followed by 200 mg/24 hours by continuous infusion or divided doses; do not wait for cortisol results
  2. CT or MRI brain — CT is faster and rules out subarachnoid hemorrhage; MRI with gadolinium defines pituitary pathology better but may not be immediately available
  3. Neurosurgical consultation — urgent transsphenoidal decompression is indicated when visual acuity or visual fields are deteriorating, CN palsy does not improve within 24 to 48 hours, or consciousness is declining
  4. Conservative management — clinically stable patients with mild symptoms and improving cranial nerve deficits may be managed non-operatively with close monitoring

Distinguishing from Subarachnoid Hemorrhage

Both present with sudden severe headache and both may show blood on CT. Key distinguishing features of apoplexy include a known pituitary adenoma, visual symptoms, and hormonal dysfunction. SAH more commonly shows diffuse subarachnoid blood on CT, and lumbar puncture showing xanthochromia. In clinical practice both conditions may require emergent intervention and the distinction can be made after stabilization.

Back to Table of Contents

Sheehan's Syndrome

Sheehan's syndrome — postpartum pituitary necrosis — results from ischemic infarction of the pituitary gland following massive hemorrhage and hemodynamic collapse during or immediately after childbirth. It is named for Harold Leeming Sheehan, who described the condition in 1937 after studying autopsy findings in women who died from postpartum hemorrhage.

Pathophysiology

During pregnancy, the anterior pituitary enlarges dramatically — sometimes doubling in volume — due to lactotroph (prolactin-cell) hyperplasia driven by estrogen. This enlarged gland sits in the rigid bony confines of the sella turcica with limited collateral blood supply. When massive postpartum hemorrhage causes systemic hypotension and spasm of the portal vessels supplying the anterior pituitary, the gland infarcts. The posterior pituitary is spared in most cases because it has a direct arterial supply independent of the portal system.

Clinical Recognition

The classic presentation follows a specific temporal pattern:

In resource-limited settings where obstetric care is suboptimal, women may suffer for years or decades before diagnosis. A history of difficult delivery with significant blood loss in a woman presenting with secondary amenorrhea, hypothyroidism, and adrenal insufficiency should prompt immediate pituitary evaluation.

Diagnosis and Treatment

MRI of the pituitary in established Sheehan's syndrome shows an empty or partially empty sella — evidence of the infarcted and resorbed pituitary tissue. Hormone replacement follows the same principles as other forms of hypopituitarism: cortisol replacement is initiated first, followed by levothyroxine, then sex hormone replacement. Fertility can sometimes be restored with gonadotropin stimulation. GH replacement is also appropriate in documented deficiency. Desmopressin is rarely needed since the posterior pituitary is usually spared.

Back to Table of Contents

Diagnosis

Diagnosing hypopituitarism requires a combination of baseline hormone measurements, dynamic stimulation tests, and pituitary imaging. The clinical context — including personal history of pituitary tumor, cranial radiation, head trauma, or complicated delivery — should prompt appropriate testing even when baseline results appear only borderline abnormal.

Imaging

MRI of the pituitary with gadolinium contrast is the imaging study of choice. It defines tumor anatomy, post-treatment change, hypothalamic involvement, stalk abnormalities, and cavernous sinus extension. CT is used when MRI is contraindicated or as an emergency tool to rule out hemorrhage.

Cortisol and ACTH Axis

Thyroid Axis

Free T4 (not TSH) is the reliable marker for secondary hypothyroidism. TSH is low, normal, or mildly elevated with biologically inactive isoforms — TSH alone will miss central hypothyroidism. Free T4 below the lower reference limit in the setting of low or normal TSH is diagnostic.

Gonadal Axis

In women: serum estradiol and LH/FSH. Premenopausal women with amenorrhea showing low estradiol and inappropriately low (not elevated) FSH/LH have secondary hypogonadism. In men: morning total and free testosterone with simultaneous LH/FSH. Low testosterone with low or normal gonadotropins confirms secondary hypogonadism.

Growth Hormone Axis

IGF-1 is the best single screening test but can be normal in mild GH deficiency. Definitive diagnosis requires a stimulation test (ITT or glucagon stimulation). GH peak less than 3 ng/mL on ITT indicates severe GH deficiency. BMI-adjusted cut-offs apply because obesity suppresses GH secretion independently.

ADH and Water Balance

Serum sodium, plasma osmolality, and urine osmolality are the initial tests. In central DI, plasma osmolality is elevated (or normal) while urine osmolality is inappropriately low (<300 mOsm/kg). A water deprivation test with desmopressin response confirms the diagnosis and distinguishes central from nephrogenic DI.

Back to Table of Contents

Treatment and Hormone Replacement

Treatment of hypopituitarism is lifelong hormone replacement tailored to each deficient axis. The sequence in which replacement is initiated matters, particularly when multiple deficiencies coexist.

Sequence of Replacement — Order Matters

Always replace cortisol (hydrocortisone) before initiating levothyroxine for coexisting central hypothyroidism. Starting thyroid hormone in a cortisol-deficient patient accelerates cortisol metabolism and can precipitate life-threatening adrenal crisis. Similarly, evaluate the adrenal axis before starting GH replacement.

Hydrocortisone for ACTH Deficiency

Physiological replacement typically uses hydrocortisone 15 to 25 mg/day in two or three divided doses (e.g., 10 mg on waking, 5 mg at noon, with or without 5 mg in late afternoon). The largest dose is taken in the morning to mimic the physiological cortisol peak. Patients must be educated about sick-day rules: doubling or tripling the daily dose during febrile illness, vomiting, or minor surgical procedures, and using parenteral hydrocortisone (100 mg IM injection) for vomiting or inability to take oral medications. An emergency injection kit (Solu-Cortef Act-O-Vial 100 mg or equivalent) should be carried at all times. Medical alert identification (bracelet or card) stating "adrenal insufficiency — requires emergency hydrocortisone" is essential.

Levothyroxine for TSH Deficiency

Levothyroxine is initiated after cortisol replacement is established. The dose targets free T4 in the mid-to-upper half of the reference range. TSH cannot be used to monitor adequacy of replacement in central hypothyroidism — the feedback loop is broken. Typical starting doses are lower in older patients and those with known cardiac disease.

Sex Hormone Replacement

In women, estrogen replacement (with progesterone if the uterus is intact) restores bone density, libido, cardiovascular markers, and quality of life. Transdermal estrogen avoids first-pass hepatic effects on clotting factors. In men, testosterone replacement (gel, injection, or patch) restores libido, erectile function, muscle mass, bone density, and energy. When fertility is desired, gonadotropin injections (FSH + LH analogs) or pulsatile GnRH can stimulate gametogenesis.

Growth Hormone Replacement

GH is replaced by daily subcutaneous injection. Doses are lower than in pediatric GH deficiency. Treatment improves body composition (decreased visceral fat, increased lean mass), bone mineral density, lipid profiles, and quality of life. Side effects include fluid retention, arthralgia, and carpal tunnel syndrome at higher doses. IGF-1 is monitored to ensure levels remain within the age-adjusted reference range. GH replacement is contraindicated in active malignancy.

Desmopressin (DDAVP) for Central Diabetes Insipidus

Desmopressin is a synthetic ADH analog available as nasal spray, sublingual tablet, or oral tablet. It reduces urine output dramatically by increasing renal water reabsorption. The dose is titrated individually; the primary risk is hyponatremia from excessive water retention if fluid intake is not appropriately matched. Patients are advised to allow a brief period of breakthrough polyuria once daily (typically in the morning before the first dose) to prevent progressive hyponatremia from accumulation.

Patient Education and Safety

The most preventable cause of death in hypopituitary patients is adrenal crisis from inadequate stress dosing of glucocorticoids. Every patient with ACTH deficiency needs:

Back to Table of Contents

Research Papers

  1. Prabhakar VK, Shalet SM (2006). Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J, 82(966):259-266. PMID: 16597826. doi:10.1136/pgmj.2005.039768
  2. Schneider HJ, et al (2007). Hypopituitarism. Lancet, 369(9571):1461-1470. PMID: 17467517. doi:10.1016/S0140-6736(07)60673-4
  3. Tanriverdi F, et al (2010). Pituitary dysfunction after traumatic brain injury. J Neurotrauma, 27(3):541-552. PMID: 19743899. doi:10.1089/neu.2009.0913
  4. Gei-Guardia O, et al (2011). Sheehan syndrome in Costa Rica. Endocr Pract, 17(3):337-344. PMID: 21134866. doi:10.4158/EP10070.OR
  5. Caturegli P, et al (2005). Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol, 153(3):363-371. PMID: 16131604. doi:10.1530/eje.1.01943
  6. Rajasekaran S, et al (2011). UK guidelines for the management of pituitary apoplexy. Clin Endocrinol, 74(1):9-20. PMID: 20840505. doi:10.1111/j.1365-2265.2010.03913.x
  7. Filipsson H, et al (2006). The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab, 91(10):3954-3961. PMID: 16868073. doi:10.1210/jc.2006-0524
  8. Murray RD, et al (2010). Optimal GH replacement in hypopituitary adults. Clin Endocrinol, 72(6):741-748. PMID: 19909371. doi:10.1111/j.1365-2265.2009.03702.x
  9. Vance ML (1994). Hypopituitarism. N Engl J Med, 330(23):1651-1662. PMID: 8177268. doi:10.1056/NEJM199406093302306
  10. Tomlinson JW, et al (2001). Association between premature mortality and hypopituitarism. Lancet, 357(9254):425-431. PMID: 11273062. doi:10.1016/S0140-6736(00)04006-X
  11. Bates AS, et al (1996). The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab, 81(3):1169-1172. PMID: 8772589. doi:10.1210/jcem.81.3.8772589
  12. Melmed S, et al (2011). Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 96(2):273-288. PMID: 21296991. doi:10.1210/jc.2010-1692

PubMed Topic Searches

  1. Hypopituitarism diagnosis and treatment
  2. Pituitary apoplexy management
  3. Sheehan syndrome postpartum pituitary
  4. Traumatic brain injury pituitary dysfunction
  5. Adrenal crisis glucocorticoid replacement
  6. Growth hormone deficiency adults quality of life

Back to Table of Contents

Connections

Back to Table of Contents